n

null

Canadians may be eligible for a class action related to a drug used to treat depression and schizophrenia.

Opening soonCanada-wideClaim deadline: Pending court decisionEstimated payout: Compensation pendingClaims not open yet

About this settlement

A class action lawsuit concerning a drug for depression and schizophrenia, potentially affecting Canadians.

This is a class action lawsuit that may involve Canadians. The lawsuit pertains to a drug used in the treatment of depression and schizophrenia. Further details on eligibility and the claims process will be provided once available.

Who qualifies

  • Canadians who may have used or been affected by the drug.
  • Specific eligibility criteria will be determined when claims open.

Compensation pending

Claim deadline: Pending court decision

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

79 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

729 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon